The data suggest a possible direct effect of MOR on opioid and growth factor-signalling and consequent proliferation, migration and epithelial mesenchymal transition (EMT) during lung cancer progression. DAMGO, morphine and fentanyl were used as MOR agonists. The gene discussed is OPRM1; the disease is lung carcinoma.